Literature DB >> 23401411

It is worth including assessment of disease activity state in juvenile arthritis clinical trials.

Alessandro Consolaro, Angelo Ravelli.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23401411     DOI： 10.1002/acr.21973

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  3 in total

1.  Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.

Authors:  Daniel B Horton; Karen B Onel; Timothy Beukelman; Sarah Ringold
Journal:  J Rheumatol       Date:  2017-02-01       Impact factor: 4.666

2.  Paediatric rheumatic disease: What is the best definition of clinical remission in JIA?

Authors:  Gabriella Giancane; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2017-06-29       Impact factor: 20.543

Review 3.  Innovative Research Design to Meet the Challenges of Clinical Trials for Juvenile Dermatomyositis.

Authors:  Silvia Rosina; Giulia Camilla Varnier; Marta Mazzoni; Stefano Lanni; Clara Malattia; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2018-04-10       Impact factor: 4.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.